T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Amgen
AMGN
$226B
| $512M | 0.07% |
2,780,461
+239,576
| +9% | +$42.9M |
|
277
AvalonBay Communities
AVB
$26.3B
| $510M | 0.07% |
2,511,273
+187,752
| +8% | +$38M |
|
278
VF Corp
VFC
$5.79B
| $507M | 0.07% |
5,804,466
+3,374,752
| +139% | +$291M |
|
279
Boston Beer
SAM
$1.9B
| $499M | 0.07% |
1,321,557
+40,011
| +3% | +$12.7M |
|
|
SRE.PRA
280
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $498M | 0.07% |
4,397,221
+65,463
| +2% | +$7.14M |
|
|
SEE
281
DELISTED
Sealed Air
SEE
| $498M | 0.07% |
11,645,140
-21,126
| -0.2% | -$930K |
|
282
Descartes Systems
DSGX
$6.62B
| $495M | 0.07% |
13,402,856
+1,697,992
| +15% | +$66.1M |
|
283
Ollie's Bargain Outlet
OLLI
$4.7B
| $489M | 0.07% |
5,616,150
+3,059,692
| +120% | +$289M |
|
|
JBTM
284
JBT Marel
JBTM
$6.1B
| $483M | 0.07% |
3,990,103
+96,972
| +2% | +$10.4M |
|
|
JBGS
285
JBG SMITH
JBGS
$692M
| $478M | 0.07% |
12,155,754
+3,774,482
| +45% | +$155M |
|
286
Illinois Tool Works
ITW
$82.9B
| $473M | 0.07% |
3,133,549
-745,959
| -19% | -$113M |
|
|
AGN
287
DELISTED
Allergan plc
AGN
| $469M | 0.07% |
2,798,601
+463,755
| +20% | +$64.2M |
|
|
PRAH
288
DELISTED
PRA Health Sciences, Inc.
PRAH
| $466M | 0.07% |
4,699,572
+3,967,806
| +542% | +$379M |
|
|
WUBA
289
DELISTED
58.com Inc
WUBA
| $466M | 0.07% |
7,487,953
+2,173,736
| +41% | +$140M |
|
290
Costco
COST
$427B
| $461M | 0.06% |
1,745,084
+2,498
| +0.1% | +$623K |
|
|
SPR
291
DELISTED
Spirit AeroSystems
SPR
| $458M | 0.06% |
5,628,445
-978,700
| -15% | -$82.5M |
|
292
Alkermes
ALKS
$8.3B
| $457M | 0.06% |
20,275,957
+697,027
| +4% | +$19.1M |
|
293
Newmont
NEM
$120B
| $457M | 0.06% |
11,868,501
+1,380,005
| +13% | +$46.6M |
|
294
Sherwin-Williams
SHW
$87.8B
| $455M | 0.06% |
2,975,316
-562,086
| -16% | -$84M |
|
295
Old Dominion Freight Line
ODFL
$44.7B
| $454M | 0.06% |
9,134,316
+2,679,297
| +42% | +$130M |
|
296
Rollins
ROL
$17.4B
| $454M | 0.06% |
18,990,393
+2,741,988
| +17% | +$70.7M |
|
297
Acadia Healthcare
ACHC
$2.82B
| $453M | 0.06% |
12,948,593
-649,625
| -5% | -$21M |
|
|
AABA
298
DELISTED
Altaba Inc
AABA
| $447M | 0.06% |
6,442,115
-2,160,692
| -25% | -$151M |
|
299
Delta Air Lines
DAL
$60B
| $446M | 0.06% |
7,859,504
-440,913
| -5% | -$24.7M |
|
300
Skyworks Solutions
SWKS
$10.5B
| $442M | 0.06% |
5,713,927
+9,818
| +0.2% | +$778K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.